Bladder cancer
Bladder cancer risk overall was associated with GSTO2 Asn142Asp (homozygous; OR=1.4; 95% CI: 1.0-1.9; P for trend=0.06) and GSTZ1 Glu32Lys (homozygous; OR=1.3; 95% CI: 0.9-1.8; P for trend=0.06).
<span class="disease" id="22306368-7-0-14">Bladder cancer</span> risk overall was associated with GSTO2 Asn142Asp (homozygous; OR=1.4; 95% CI: 1.0-1.9; P for trend=0.06) and <span class="gene" id="22306368-7-124-129">GSTZ1</span> Glu32Lys (homozygous; OR=1.3; 95% CI: 0.9-1.8; P for trend=0.06).